ABBV - AbbVie to secure $38B bridge loan for Allergan transaction June, 26 2019 07:30 AM AbbVie Inc. Bloomberg reports that AbbVie (NYSE:ABBV) intends to syndicate a $38B 364-day bridge loan for its acquisition of Allergan (NYSE:AGN).More news on: AbbVie Inc., Allergan plc, Healthcare stocks news, Merger & acquisition news, Read more ...